glp-1 agonists in development Understanding receptor and their impact on drug discovery Evolution of GLP‐1 Receptor Agonists

Efficacy and safety of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as monotherapy or add-on to metformin in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

As mentioned in the case of CagriSema, natural amylin is a pancreatic hormone that induces satiety and Cagrilintide is a long-acting amylin analogue

It is used as an adjunctive therapy, along with diet and exercise, to help manage blood sugar levels and promote weight reduction in adults with T2DM [61]

However, concerns about their potential link to cancers, such as thyroid cancer, have surfaced

Available from: Xiao P, Wang H, Liu H, Yuan H, Guo C, Feng Y, et al

GLP-1 medications are driving significant shifts in the pharmaceutical market, with soaring demand, rising prescriptions, and multi-billion-dollar growth projections